Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Guaraldi

Showing results (11-20 of 408) with videos related to

Pageof 41
Sort By:
AIDS (London, England)|September 2, 2022
Hormone therapy in postmenopausal women living with HIV: a view towards prevention of multiple metabolic conditions and improvement of quality of lifeJovana Milic, Giovanni Guaraldi
Atherosclerosis|October 4, 2017
Atherosclerosis in frailty: Not frailty in atherosclerosisGiovanni Guaraldi, Paolo Raggi
Drugs & Aging|May 9, 2018
Pre-exposure Prophylaxis for HIV Infection in the Older Patient: What can be Recommended?Iacopo Franconi, Giovanni Guaraldi
Atherosclerosis|July 12, 2017
Antiretroviral therapies and cardiovascular risk: True or false?Giovanni Guaraldi, Paolo Raggi
The Lancet. HIV|December 23, 2023
The best place for doravirineCristina Mussini, Giovanni Guaraldi
Current Opinion in Pulmonary Medicine|March 14, 2023
Drug treatment of COVID-19 infectionGrace Lui, Giovanni Guaraldi
Endocrinology and Metabolism Clinics of North America|August 30, 2014
Hypogonadism in the HIV-infected manVincenzo Rochira, Giovanni Guaraldi
AIDS (London, England)|December 27, 2019
Vitamin E as a 'bridge' therapy for nonalcoholic steatohepatits in HIV: what is waiting on the other side of the bridge?Giovanni Guaraldi, Jovana Milic
The Journal of Infectious Diseases|September 21, 2019
Why Am I Getting Fat? Exploring Immune-Metabolic Pathways to Central Fat Accumulation in Persons With HIVGiovanni Guaraldi, Jovana Milic
Current Opinion in HIV and AIDS|February 1, 2023
Impact of coronavirus disease 2019 on co-morbidities in HIVGiovanni Guaraldi, Jovana Milic
Pageof 41

Showing results (11-20 of 408) with videos related to

Sort By:
Pageof 41
AIDS (London, England)|September 2, 2022
Hormone therapy in postmenopausal women living with HIV: a view towards prevention of multiple metabolic conditions and improvement of quality of lifeJovana Milic, Giovanni Guaraldi
Atherosclerosis|October 4, 2017
Atherosclerosis in frailty: Not frailty in atherosclerosisGiovanni Guaraldi, Paolo Raggi
Drugs & Aging|May 9, 2018
Pre-exposure Prophylaxis for HIV Infection in the Older Patient: What can be Recommended?Iacopo Franconi, Giovanni Guaraldi
Atherosclerosis|July 12, 2017
Antiretroviral therapies and cardiovascular risk: True or false?Giovanni Guaraldi, Paolo Raggi
The Lancet. HIV|December 23, 2023
The best place for doravirineCristina Mussini, Giovanni Guaraldi
Current Opinion in Pulmonary Medicine|March 14, 2023
Drug treatment of COVID-19 infectionGrace Lui, Giovanni Guaraldi
Endocrinology and Metabolism Clinics of North America|August 30, 2014
Hypogonadism in the HIV-infected manVincenzo Rochira, Giovanni Guaraldi
AIDS (London, England)|December 27, 2019
Vitamin E as a 'bridge' therapy for nonalcoholic steatohepatits in HIV: what is waiting on the other side of the bridge?Giovanni Guaraldi, Jovana Milic
The Journal of Infectious Diseases|September 21, 2019
Why Am I Getting Fat? Exploring Immune-Metabolic Pathways to Central Fat Accumulation in Persons With HIVGiovanni Guaraldi, Jovana Milic
Current Opinion in HIV and AIDS|February 1, 2023
Impact of coronavirus disease 2019 on co-morbidities in HIVGiovanni Guaraldi, Jovana Milic
Pageof 41